Large retailers such as Home Depot, Staples and Lowe's are devoting more and more floor space to such products, even though it is unclear how large the market for them is today.

Home improvement retailers Home Depot Inc. and Lowe's Cos. began prepping for the aftermath of the storm, sending truckloads of generators, water and batteries into warehouses and stores along the Eastern Seaboard.

家庭装修零售商家得宝（Home Depot Inc.）和劳氏（Lowe's Cos.）已经开始把大批的发电机、饮用水和电池运往东部沿海地区的仓库和商店，为飓风可能造成的后果做好准备。

Lowe: He's merely a voice to the truth I speak.

罗维：因为他只不过是对我所说的真理表示反对的声音。

Home improvement retailer Lowe's is releasing an app that enables Phab2 Pro users to measure spaces with the phone and test how digital replicas of appliances and other decor would look around a house.

家装用品零售商美国劳氏公司即将发布的一款应用程序可实现Phab2Pro手机用户用手机测量空间及测试家居用品和房内其他装饰的数字模型是否适合房间尺寸。

Executives at CVS Health, a leading pharmacy benefits manager, recently said that PCSK9 inhibitors might cost$ 7000 to$ 12000 a year and would strain health care budgets because so many people might use them.

CVS健康公司（CVS Health）是美国名列前茅的一家医药福利管理公司，其高管最近表示，在PCSK9抑制剂上的年花费预计达7000美元至12000美元，由于使用者人数众多，它将给医疗预算带来沉重的压力。

But Dr. William Shrank, chief scientific officer at CVS Health, estimates they will cost$ 7000 to$ 12000 a year.

但CVS健康公司（CVS Health）的首席科学官威廉·史兰克（William Shrank）估计，服用这种药物一年将需要7000至1.2万美元。

The leading flu-vaccine manufacturers include Sanofi and Novartis.

领先的流感疫苗生产商包括赛诺菲和诺华。

Sanofi resubmitted the drug to the FDA last year after carrying out new trials, the most important of which was published Wednesday in the New England Journal of Medicine.

在进行了新的临床研究之后，赛诺菲于去年再次向FDA提出申请。该研究的关键部分发表在周三的《新英格兰医学杂志》上。

France's Sanofi paid$ 4.6 billion for Ablynx, a Ghent-based medical company that does llama antibody research, in 2018.

2018年，法国赛诺菲公司斥资46亿美元收购了总部位于根特、从事羊驼抗体研究的医疗公司Ablynx。

Sanofi's cancer products are ageing.

赛诺菲的抗癌药生产正在逐渐成熟。

Attesting to the feasibility of this approach, Sanofi Pasteur has played a key role in transferring influenza vaccine technology to Brazil which will be in a position to produce vaccine next year.

证明这一举措的可行性，Sanofi Pasteur已在向巴西转让流感疫苗技术方面发挥关键作用，巴西明年将能够生产疫苗。

The drugs, evolocumab from Amgen and alirocumab from Sanofi and Regeneron, inhibit a protein in the body called PCSK9 that helps regulate cholesterol.

这两种新药分别是安进公司（Amgen）研发的evolocumab，以及赛诺菲和瑞泽恩（Sanofi and Regeneron）制药公司的alirocumab，它们的作用机理都是抑制PCSK9——体内的一种协助调节胆固醇的蛋白质。

Sanofi, the world's third-largest drugmaker, already has a significant commercial presence in China and is conducting many clinical trials in the country.

赛诺菲，作为世界第三大制药公司，在中国已经有一个重要的商业地位，并正在进行多项临床试验。

One is a primer dose made by Sanofi Pasteur, the vaccine division of French drug maker Sanofi-Aventis;

其一是法国药品制造商赛诺菲安万特（Sanofi-Aventis）旗下生产疫苗的子公司Sanofi Pasteur生产的基础疫苗；

Those strains are then produced and handed off to manufacturers, such as GlaxoSmithKline, Novartis and Sanofi, to produce and distribute-a process that requires significant lead time to ensure the doses reach doctor offices by early October.

这些病毒株会被大量生产，然后交给葛兰素史克、诺华和赛诺菲等生产厂家来生产和销售——这个过程需要显著的提前期，才能保证疫苗在10月初到达各地的医院。

Sanofi bought an F.D.A.-backed voucher for$ 67.5 million that gave them an expedited review.

赛诺菲以6750万美元的价格购买了FDA的批文，可以获得快速审核。

Sanofi says it will notify the healthcare professionals involved in the trials later today.

赛诺菲称，当天晚些时候将通知临床试验相关的所有医疗卫生专家。

The company has licensed experimental treatments from big pharma partners including Sanofi and Bristol-Myers Squibb, but Ms Du's long-term focus is on developing homegrown drugs.

再鼎医药从赛诺菲（Sanofi）和百时美施贵宝（Bristol-Myers Squibb）等大型制药商伙伴那里，获得了一些处于临床试验阶段的药物的授权，但杜莹的长期目标在于研发本土药物。

Dengvaxia, manufactured by French pharmaceutical giant Sanofi, secured its first regulatory approval in Mexico a fortnight ago and is currently being reviewed by around 20 countries in Asia and Latin America.

两周前，由法国制药巨头赛诺菲研发的Dengvaxia在墨西哥获得批准通过，并且在近期由20个亚洲和拉丁美洲国家审核。

Sanofi estimates that 11 million Americans might qualify.

赛诺菲估计，可能有1100万美国人有资格接受该药物。

The panel, in a 13 to 3 vote, recommended the approval of Sanofi and Regeneron Pharmaceuticals" drug, alirocumab.

这个专家委员会以13比3的投票结果，建议批准赛诺菲（Sanofi）和瑞泽恩制药公司（Regeneron Pharmaceuticals）的药物alirocumab。